Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-10-2012 | Poster presentation

Inhibition kinetics of Plasmodium Lactate Dehydrogenase with herbal extracts suggest possible enzyme inhibitor molecular interaction

Authors: Privadarshan Keluskar, Apeksha Mohile, Sanjay Ingle

Published in: Malaria Journal | Special Issue 1/2012

Login to get access

Excerpt

Resistance acquired by Plasmodium species (especially P. falciparum) to most of the present antimalarial drugs is the principal hindrance in controlling malaria. Thus, one of the major challenges towards elimination of Malaria is development of novel and sustainable antimalarial drugs. In this milieu, herbs traditionally used to treat malaria are promising repertoires of antimalarial drugs. Earlier, lab studies have reported selective inhibition of P. falciparum and P. vivax specific Lactate Dehydrogenase (PfLDH and PvLDH) by Phyllanthus amarus aqueous extract and Murraya koenigii chloroform extract respectively. In the present investigation, we studied inhibition kinetics of PfLDH and PvLDH to explore molecular interactions between enzyme and inhibitor. …
Literature
1.
go back to reference Bergmeyer HU: Methods of Enzymatic Analysis. 1981, Verlag Chemie International, Florida, 574-579. 2 Bergmeyer HU: Methods of Enzymatic Analysis. 1981, Verlag Chemie International, Florida, 574-579. 2
2.
go back to reference Shoemark DK, Cliff MJ, Sessions RB, Clarke AR: Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum. FEBS Journal. 2007, 274: 2738-2748. 10.1111/j.1742-4658.2007.05808.x.CrossRefPubMed Shoemark DK, Cliff MJ, Sessions RB, Clarke AR: Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum. FEBS Journal. 2007, 274: 2738-2748. 10.1111/j.1742-4658.2007.05808.x.CrossRefPubMed
Metadata
Title
Inhibition kinetics of Plasmodium Lactate Dehydrogenase with herbal extracts suggest possible enzyme inhibitor molecular interaction
Authors
Privadarshan Keluskar
Apeksha Mohile
Sanjay Ingle
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-S1-P56

Other articles of this Special Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine